Company Filing History:
Years Active: 2006
Title: Seishi Kyoizumi: Innovator in Monoclonal Antibody Research
Introduction
Seishi Kyoizumi is a prominent inventor based in Aki, Japan. He is known for his significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. His work has implications for both research and clinical applications, especially in the isolation and purification of stem cells.
Latest Patents
Kyoizumi holds a patent for a monoclonal antibody, its immunoreactive fragment, and hybridoma. This patent focuses on utilizing a novel HSCA-3 antigen that occurs in immature hemopoietic stem cells. The invention is aimed at enhancing immunoassays and flow cytometry through antibody labeling. Additionally, it facilitates the isolation and purification of immature hemopoietic stem cells from human bone marrow, umbilical cord blood, or blood enriched in these cells through mobilization with G-CSF.
Career Highlights
Seishi Kyoizumi is associated with Kaneka Corporation, where he has made significant strides in his research. His innovative work has led to advancements in the understanding and application of monoclonal antibodies in medical science. His patent is a testament to his expertise and dedication to the field.
Collaborations
Kyoizumi has collaborated with notable colleagues, including Takaaki Ohara and Kenji Yamashita. These partnerships have contributed to the success of his research and the development of his patented technologies.
Conclusion
Seishi Kyoizumi's contributions to the field of immunology through his patented monoclonal antibody research highlight his role as an influential inventor. His work continues to impact the scientific community and offers promising avenues for future research and clinical applications.